Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agence Regionale de Sante d'Ile de France | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether telemedicine would be as effective as having a pediatrics ophthalmologist on site for screening examination of retinopathy in premature infants and would be cost-effective.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exposed group, during Tele-expertise | Infants hospitalized in health facilities performing tele-expertise |
| |
| Exposed group, Prior Tele-expertise | Infants hospitalized in health facilities performing Tele-expertise prior implementation of Tele-expertise | ||
| Control group, Prior Tele-expertise | |||
| Control group, during Tele-expertise | Infants hospitalized in health facilities not performing Tele-expertise while the exposed group use Tele-expertise |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Infants hospitalized in health facilities performing Tele-expertise | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of premature infants being screened for retinopathy following recommendations | Proportion of premature infants being screened for retinopathy following recommendations (between 31 and 32 weeks of amenorrhea (WA) for infants born before 28 WA and during the fourth week of life for infants born after 28 WA) | 4 weeks in average |
| Measure | Description | Time Frame |
|---|---|---|
| Delay before the first screening of retinopathy | For infants born at or after 28WA | 4 weeks in average |
| Cost of telemedicine | 6 months after enrollment of the first patient |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Infants hospitalized in neonatology unit
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Isabelle Durand-Zaleski, MD, PhD | DRCD URC Eco. Assistance Publique, Hôpitaux de Paris | Principal Investigator |
| Michele Granier, MD | Centre Hospitalier Sud Francilien | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Service de réanimation néonatale. Centre Hospitalier Sud Francilien | Corbeil-Essonnes | 91100 | France | |||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 22617736 | Background | Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638. | |
| 23277315 | Background | Fierson WM; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013 Jan;131(1):189-95. doi: 10.1542/peds.2012-2996. Epub 2012 Dec 31. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012178 | Retinopathy of Prematurity |
| ID | Term |
|---|---|
| D012164 | Retinal Diseases |
| D005128 | Eye Diseases |
| D007235 | Infant, Premature, Diseases |
| D007232 | Infant, Newborn, Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Service de réanimation néonatale. Maternité de Port-Royal |
| Paris |
| 75014 |
| France |
| 26857558 | Derived | Charrier N, Zarca K, Durand-Zaleski I, Calinaud C; ARS Ile de France telemedicine group. Efficacy and cost effectiveness of telemedicine for improving access to care in the Paris region: study protocols for eight trials. BMC Health Serv Res. 2016 Feb 8;16:45. doi: 10.1186/s12913-016-1281-1. |
| D009358 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities |